End-of-life sedative caused significant number of U.K. care home deaths during pandemic – NaturalNews.com

• A new academic paper alleges that a significant number of U.K. care home deaths in early 2020 were caused not by COVID-19, but by the widespread and inappropriate use of the end-of-life sedative midazolam.
• The research, published in Medical and Clinical Research, claims this practice falsely inflated the virus’s perceived deadliness, which was then used to justify severe global restrictions.
• The paper’s author and commentator Dr. John Campbell argue that palliative care protocols (midazolam with morphine) for breathlessness were broadly applied to non-terminal COVID-19 patients, leading to what is described as systemic euthanasia.
• The core statistical claim is a strong correlation between spikes in midazolam shipments to care homes and subsequent rises in excess deaths about one month later, suggesting the drug drove mortality.
• The allegations point to a catastrophic failure in patient care and data reporting, raising profound ethical questions and demanding a transparent investigation into midazolam use and patient status during the pandemic’s peak.

A startling new academic paper is making waves by alleging that a significant portion of deaths attributed to the Wuhan coronavirus (COVID-19) in the U.K., particularly in care homes during the pandemic’s first wave, were not caused by the virus but by the widespread, inappropriate use of powerful end-of-life drugs. The research posits a systemic failure that falsely inflated the perceived deadliness of the virus, which in turn was used to justify sweeping global restrictions.

Published in the journal Medical and Clinical Research, the analysis by researcher Wilson Sy, Ph.D., focuses on the sedative midazolam. The paper concludes that its use in care homes was “widespread and correlated with increased levels of excess deaths.” The author goes further, alleging that NHS executives manipulated COVID-19 fatality figures through two primary methods: instructing medical staff to provide minimal care and directing the euthanization of patients via the End of Life Care program using midazolam, with both sets of deaths falsely listed as COVID-19 fatalities.

According to BrightU.AI‘s Enoch, midazolam is an ultrashort-acting benzodiazepine used to induce sedation and amnesia during medical procedures. It is also crucial for managing acute anxiety, agitation or psychosis following overdoses of stimulants or hallucinogens like amphetamines or LSD.

These claims have been amplified by medical commentator Dr. John Campbell, who calls the situation a “complete national outrage that is largely being ignored.” On commentator Russell Brand’s podcast, Campbell detailed how guidelines from the U.K.’s National Institute for Health and Care Excellence (NICE) in April 2020 recommended using midazolam alongside morphine to treat breathlessness in adults during the final days of life. Campbell argues this protocol was broadly applied to COVID-19 patients who were not necessarily terminal.

“The majority of these patients, in my view, in care facilities that died in 2020, if they’d just been supported and not given morphine and midazolam, the vast majority of those would have made a full recovery,” Campbell told Brand. He described the practice as “essentially euthanasia on a huge scale.”

The core of Sy’s statistical analysis, as explained by Campbell, tracks shipments of midazolam to care homes against subsequent excess death data. Campbell claims the research shows “precise correlations” between spikes in drug distribution and rises in deaths approximately one month later. When the death data is shifted to account for distribution delays, Campbell said the curves matched closely, following each other “like salt and pepper.”

Sedative overdose inflated COVID fatality rate in 2020

This correlation, Campbell argues, suggests drug use, not the SARS-CoV-2 virus, drove much of the mortality in care facilities in 2020. The consequence, he states, was a dramatic distortion of the virus’s perceived threat. He claims the reported infection fatality rate appeared to be as high as 24% during this period, while later estimates settled near 0.18%.

“All those COVID restrictions, you could argue that many of them came in as a result of this artificially inflated infection fatality rate when, in actual fact, the lockdowns and the vaccinations didn’t work against midazolam overdose, which was a big part of the problem,” Campbell asserted.

The paper and Campbell’s commentary present a damning narrative: that a lethal medical protocol, justified by pandemic guidelines, caused a wave of preventable deaths. These deaths were then miscategorized, creating a feedback loop of fear that legitimized unprecedented public health policies. The allegations point to a potential catastrophic failure in patient triage and palliative care standards during a crisis, raising profound ethical questions about the stewardship of the most vulnerable during the pandemic’s peak.

The NHS and relevant U.K. health authorities have historically defended the use of palliative protocols during the pandemic as necessary for compassionate symptom management in the face of a novel and overwhelming disease. These new claims, however, demand a rigorous and transparent investigation into the prescription patterns of midazolam in 2020 and the true clinical status of the patients who received it.

Watch this video about euthanasia, assisted suicide and hospice care.

This video is from the CHP Canada channel on Brighteon.com.

Sources include:

BrightU.ai

ChildrensHealthDefense.org

Brighteon.com